Clinical trial · Observational
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967CI-TRIAL-00066791unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this project was to use multi-omics technology to screen the key factors for the occurrence and development of uterine sarcoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Sarcoma | Uterine Corpus Sarcoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnostic biomarker | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Uterine sarcoma
- description
- Participants were enrolled for the first treatment of uterine sarcoma or secondary operation for recurrence fo uterine sarcoma.
- interventionNames
- Diagnostic Test: Diagnostic biomarker
- label
- Uterine fibroid
- description
- Participants were enrolled for surgery of uterine fibroids.
- interventionNames
- Diagnostic Test: Diagnostic biomarker
Primary outcomes (1)
- measure
- Susceptible gene in women with uterine sarcoma
- timeFrame
- baseline
- description
- Analyze genetic susceptibility among women exhibiting disease manifestations of uterine sarcoma
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age 18 or older; 2. Newly treated or recurenced uterine sarcoma. Exclusion Criteria: 1. Diagnosis of other malignancies within the past 5 years; 2. history of pelvic or vaginal radiation therapy; 3. Known high-grade lesions of the cervix and endometrium.
References
Publications (0)
Data not yet available
No reference posted for this study.